Human testing of the first anti-nicotine vaccine has begun, according to
British drugs company Xenova. Medical director John Roberts says the drug could
help people quit because it prevents nicotine acting on the brain and so stops
addiction. Nicotine patches or gum simply substitute inhaled nicotine with a
more benign form. The vaccine will work best for smokers who risk relapsing
after quitting. The vaccine will stop a lapse of will power “sending you back to
the beginning of the craving cycle”, says Roberts.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Are Neanderthals descendants of modern humans?
2
Exclusive report: Inside Chernobyl, 40 years after nuclear disaster
3
Electric vehicle owners could earn thousands by supporting power grid
4
How autoimmune conditions can unexpectedly drive mental illness
5
The man who crawls into the perilous heart of the Chernobyl reactor
6
Beef is making a comeback – does it fit into a healthy diet?
7
My life as a meteorologist in Chernobyl under Russian occupation
8
Neanderthal infants were enormous compared with modern humans
9
Collapse of key ocean current may release billions of tonnes of carbon
10
A key solution to climate change isn't happening – and that's good
